Suppr超能文献

细胞周期调节蛋白在肌肉浸润性膀胱癌中的预后价值

Prognostic value of cell cycle regulatory proteins in muscle-infiltrating bladder cancer.

作者信息

Galmozzi Fabia, Rubagotti Alessandra, Romagnoli Andrea, Carmignani Giorgio, Perdelli Luisa, Gatteschi Beatrice, Boccardo Francesco

机构信息

Department of Medical Oncology, University of Genova, Genova, Italy.

出版信息

J Cancer Res Clin Oncol. 2006 Dec;132(12):757-64. doi: 10.1007/s00432-006-0123-7. Epub 2006 Jun 21.

Abstract

PURPOSE

The aims of this study were to investigate the expression levels of proteins involved in cell cycle regulation in specimens of bladder cancer and to correlate them with the clinicopathological characteristics, proliferative activity and survival.

METHODS

Eighty-two specimens obtained from patients affected by muscle-invasive bladder cancer were evaluated immunohistochemically for p53, p21 and cyclin D1 expression, as well as for the tumour proliferation index, Ki-67. The statistical analysis included Kaplan-Meier curves with log-rank test and Cox proportional hazards models.

RESULTS

In univariate analyses, low Ki-67 proliferation index (P = 0.045) and negative p21 immunoreactivity (P = 0.04) were associated to patient's overall survival (OS), but in multivariate models p21 did not reach statistical significance. When the combinations of the variables were assessed in two separate multivariate models that included tumour stage, grading, lymph node status, vascular invasion and perineural invasion, the combined variables p21/Ki-67 or p21/cyclin D1 expression were independent predictors for OS; in particular, patients with positive p21/high Ki-67 (P = 0.015) or positive p21/negative cyclin D1 (P = 0.04) showed the worst survival outcome.

CONCLUSIONS

Important alterations in the cell cycle regulatory pathways occur in muscle-invasive bladder cancer and the combined use of cell cycle regulators appears to provide significant prognostic information that could be used to select the patients most suitable for multimodal therapeutic approaches.

摘要

目的

本研究旨在调查膀胱癌标本中参与细胞周期调控的蛋白质表达水平,并将其与临床病理特征、增殖活性和生存率相关联。

方法

对82例肌层浸润性膀胱癌患者的标本进行免疫组织化学评估,检测p53、p21和细胞周期蛋白D1的表达,以及肿瘤增殖指数Ki-67。统计分析包括采用对数秩检验的Kaplan-Meier曲线和Cox比例风险模型。

结果

在单变量分析中,低Ki-67增殖指数(P = 0.045)和阴性p21免疫反应性(P = 0.04)与患者的总生存期(OS)相关,但在多变量模型中,p21未达到统计学意义。当在两个单独的多变量模型中评估变量组合时,这两个模型包括肿瘤分期、分级、淋巴结状态、血管侵犯和神经周围侵犯,p21/Ki-67或p21/细胞周期蛋白D1表达的组合变量是OS的独立预测因素;特别是,p21阳性/Ki-67高表达(P = 0.015)或p21阳性/细胞周期蛋白D1阴性(P = 0.04)的患者生存结果最差。

结论

肌层浸润性膀胱癌中细胞周期调控途径发生重要改变,联合使用细胞周期调节因子似乎能提供重要的预后信息,可用于选择最适合多模式治疗方法的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验